Spotlighting the most promising biotechnology companies in Israel.

Although it is a smaller country, Israel’s biotechnology sector is flourishing. According to Ernst & Young, BioIsrael has recently experienced a boost of venture capital placing it among the ranks of larger biotech companies. With more capital, IsraelBio has been able to increase the number of products within Phase III development. IsraelBio also boasts a large number of students and graduates in life sciences, showing promise for future growth and development.


Hotbed News
Mutations From Venus, Mutations From Mars, Weizmann Institute of Science Study Thursday, July 31, 2014
All Proposals Approved At Teva Pharmaceutical Industries Limited (TEVA)'s Annual Meeting Of Shareholders Thursday, July 31, 2014
BioBlast Pharma (ORPN) Prices Initial Public Offering Of $35,200,000 Of Ordinary Shares Thursday, July 31, 2014
Teva Pharmaceutical Industries Limited (TEVA) Reports Second Quarter 2014 Results Thursday, July 31, 2014
Enzymotec To Participate In The Canaccord Genuity 34th Annual Growth Conference Thursday, July 31, 2014
LabStyle Innovations Announces The Initial Launch Of The Dario™ Diabetes Management Solution For Android Devices Thursday, July 31, 2014
MediWound (MDWD) Reports Second Quarter 2014 Financial Results Thursday, July 31, 2014
Israel's Ministry Of Health Approves Pluristem Therapeutics (PSTI)'s Commercial-Scale 3D Cell Manufacturing Process Used At Its New Haifa Facility Thursday, July 31, 2014
VBL Therapeutics Announces Pricing Of Initial Public Offering Thursday, July 31, 2014
Israeli Biotech Macrocure Sets Terms for $75 Million IPO Thursday, July 31, 2014